1. Home
  2. Labeler Index
  3. Carwin Pharmaceutical Associates, Llc
  4. 15370-170
  5. NDC Package Code: 15370-170-30 Relafen Ds

NDC Package 15370-170-30 Relafen Ds

Nabumetone Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
15370-170-30
Package Description:
30 TABLET in 1 BOTTLE, PLASTIC
Product Code:
15370-170
Proprietary Name:
Relafen Ds
Non-Proprietary Name:
Nabumetone
Substance Name:
Nabumetone
Usage Information:
Nabumetone is used to reduce pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.
11-Digit NDC Billing Format:
15370017030
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2200291 - Relafen DS 1000 MG Oral Tablet
  • RxCUI: 2200291 - nabumetone 1000 MG Oral Tablet [Relafen]
  • RxCUI: 2200291 - Relafen 1000 MG Oral Tablet
  • RxCUI: 427726 - nabumetone 1000 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Carwin Pharmaceutical Associates, Llc
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • NABUMETONE 1000 mg/1
    • Pharmacologic Class(es):
  • Anti-Inflammatory Agents, Non-Steroidal - [CS]
  • Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
  • Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA203166
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    09-20-2019
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    15370-170-10100 TABLET in 1 BOTTLE, PLASTIC
    15370-170-6060 TABLET in 1 BOTTLE, PLASTIC
    15370-170-991 BLISTER PACK in 1 CARTON / 2 TABLET in 1 BLISTER PACK

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 15370-170-30?

    The NDC Packaged Code 15370-170-30 is assigned to a package of 30 tablet in 1 bottle, plastic of Relafen Ds, a human prescription drug labeled by Carwin Pharmaceutical Associates, Llc. The product's dosage form is tablet and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package.

    Is NDC 15370-170 included in the NDC Directory?

    Yes, Relafen Ds with product code 15370-170 is active and included in the NDC Directory. The product was first marketed by Carwin Pharmaceutical Associates, Llc on September 20, 2019 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 15370-170-30?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 15370-170-30?

    The 11-digit format is 15370017030. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-215370-170-305-4-215370-0170-30